Details of the Drug Combinations

General Information of This Drug (ID: DM62B78)

Drug Name

Olodaterol DM62B78

Synonyms

BI-1744

Indication

Disease Entry	ICD 11	Status	REF
Chronic obstructive pulmonary disease	CA22	Approved	[1]
------------------------------------------------------------------------------------

Drug Type

Small molecular drug

Structure

3D MOL

2D MOL

List of Combinatorial Drugs (CBD) Containing This Drug

3 Clinical Trial Drug Combination(s) Consisting of This drug

DrugCom Name	DrugCom ID	Component Drug	Indication	REF
Olodaterol + Tiotropium	DC9SWB7	Tiotropium	Pulmonary Disease, Chronic Obstructive	[2]
Olodaterol + BI-54903	DC332FF	BI-54903	Asthma	[3]
Olodaterol + Olodaterol	DC93IT0	Olodaterol	Pulmonary Disease, Chronic Obstructive	[4]
------------------------------------------------------------------------------------

References

1	URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 7543).
2	ClinicalTrials.gov (NCT01694771) Co-administration of Olodaterol Respimat and Tiotropium Handihaler
3	ClinicalTrials.gov (NCT01428622) Olodaterol Bridging Study in Asthma. U.S. National Institutes of Health.
4	ClinicalTrials.gov (NCT01040130) Effect of Treatment BI 1744 CL (5 and 10 mcg) Versus Placebo on Exercise Endurance Time During Constant Work Rate Cycle Ergometry I